SanBio Co (SanBio Co) Price-to-Tangible-Book : 13.90 (As of May. 25, 2024)

View and export this data going back to 2015. Start your Free Trial

What is SanBio Co Price-to-Tangible-Book?

As of today (2024-05-25), SanBio Co's share price is $3.85. SanBio Co's Tangible Book per Share of Jan. 2024 for the quarter that ended in Jan. 2024 was $0.28. Hence, SanBio Co's Price to Tangible Book Ratio of today is 13.90.

The historical rank and industry rank for SanBio Co's Price-to-Tangible-Book or its related term are showing as below:

SNBIF' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 6.39 Med: 12.03 Max: 215.96
Current: 11.32

During the past 11 years, SanBio Co's highest Price to Tangible Book Ratio was 215.96. The lowest was 6.39. And the median was 12.03.

SNBIF's Price-to-Tangible-Book is ranked worse than
89.93% of 1221 companies
in the Biotechnology industry
Industry Median: 2.79 vs SNBIF: 11.32

A closely related ratio is called PB Ratio. As of today, SanBio Co's share price is $3.85. SanBio Co's Book Value per Sharefor the quarter that ended in Jan. 2024 was $0.28. Hence, SanBio Co's P/B Ratio of today is 13.70.

SanBio Co Price-to-Tangible-Book Historical Data

The historical data trend for SanBio Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SanBio Co Price-to-Tangible-Book Chart

SanBio Co Annual Data

Trend

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Jan24

Price-to-Tangible-Book

Get a 7-Day Free Trial

19.13

9.68

28.40

10.38

14.44

SanBio Co Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Price-to-Tangible-Book	Get a 7-Day Free Trial															10.38	12.39	17.49	21.12	14.44

Competitive Comparison of SanBio Co's Price-to-Tangible-Book

For the Biotechnology subindustry, SanBio Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SanBio Co's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SanBio Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where SanBio Co's Price-to-Tangible-Book falls into.

SanBio Co Price-to-Tangible-Book Calculation

SanBio Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Jan. 2024 )
	=	3.85	/	0.277
	=	13.90

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

SanBio Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of SanBio Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

SanBio Co (SanBio Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SanBio Co Ltd (OTCPK:SNBIF) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

4592:Japan

Address

8-1 Street Luke Tower 32nd Floor, Akashi-cho, Chuo-ku, Tokyo, JPN, 104-0044

Website

https://www.sanbio.com

SanBio Co Ltd is engaged in the research and development of regenerative cells drugs. The company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury and Alzheimer's disease; enhanced type-mesenchymal stem cells SB618, used to treat peripheral neuropathy, as well as muscle stem cells SB308, used in the treatment of muscular dystrophy.